Skip to main content
Top
Published in: Endocrine 3/2011

01-12-2011 | Original Article

Case seminar: a young female with acute hyponatremia and a sellar mass

Authors: Sandra Pekic, Mirjana Doknic, Dragana Miljic, Alexandru Saveanu, Rachel Reynaud, Anne Barlier, Thierry Brue, Vera Popovic

Published in: Endocrine | Issue 3/2011

Login to get access

Abstract

In familial cases of combined pituitary hormone deficiency the most common mutations are that of Prophet of Pit 1 (PROP1) gene. PROP1 mutations are associated with deficiencies of growth hormone, thyrotropin, prolactin, and gonadotropins (follicle-stimulating hormone and luteinizing hormone), with evolving adrenocorticotropin (ACTH) deficiency in some cases. On imaging in most patients the pituitary gland is hypoplastic, but occasionally transient pituitary enlargement is found. We report a 22-year-old female initially diagnosed at age 12 with familial hypopituitarism due to PROP1 mutation, who presented with coma and respiratory arrest (acute hyponatremia). She was urgently treated in Intensive Care Unit of Emergency Center with hypertonic saline and stress doses of hydrocortisone, which resulted in the fast increase of plasma osmolality resulting in the osmotic demyelination syndrome. Simultaneously and incidentally on computed tomography scan a large sellar and suprasellar mass were reported as possible Rathke’s cleft cyst or craniopharyngioma. Once the patient was stable, ACTH deficiency was documented. She remained replaced with hydrocortisone and subsequently underwent transphenoidal surgery. The removed sellar content revealed no pituitary adenoma or pituitary cells, but only an eosinophilic, colloid-like mass, and necrotic acellular debris. Her sister with hypopituitarism had an empty sella. Genetic testing in both sisters revealed the same homozygous c.150delA mutation in PROP1 gene. Here we report two sisters with the same PROP1 mutation who presented in adulthood with different pituitary morphology, one of them with a large sellar and suprasellar mass, in which transphenoidal surgery provided an extremely rare opportunity for a histopathological analysis of the sellar content. Due to the lack of endocrine care during the transition period hypocortisolism which evolved, a consequence of PROP1 mutation, was not recognized. Empirical use of hydrocortisone in the Intensive Care in our patient with life-threatening acute hyponatremia was appropriate but because glucocorticoid therapy on its own corrects hyponatremia even after stopping hypertonic saline infusion, the risk for over-correction of hyponatremia in ACTH deficiency is high.
Literature
1.
go back to reference J.S. Dasen, J.P. Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju, J. Tollkuhn, S.H. Baek, D.W. Rose, M.G. Rosenfeld, Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev. 15, 3193–3207 (2001)PubMedCrossRef J.S. Dasen, J.P. Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju, J. Tollkuhn, S.H. Baek, D.W. Rose, M.G. Rosenfeld, Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev. 15, 3193–3207 (2001)PubMedCrossRef
2.
go back to reference M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, I. Gukovsky, C. Carrière, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996)PubMedCrossRef M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, I. Gukovsky, C. Carrière, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996)PubMedCrossRef
3.
go back to reference P.J. Gage, M.L. Brinkmeier, L.M. Scarlett, L.T. Knapp, S.A. Camper, K.A.L. Mahon, The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol. Endocrinol. 10, 1570–1581 (1996)PubMedCrossRef P.J. Gage, M.L. Brinkmeier, L.M. Scarlett, L.T. Knapp, S.A. Camper, K.A.L. Mahon, The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol. Endocrinol. 10, 1570–1581 (1996)PubMedCrossRef
4.
go back to reference L.E. Cohen, Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 12, 99–106 (2000)PubMedCrossRef L.E. Cohen, Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 12, 99–106 (2000)PubMedCrossRef
5.
go back to reference M.T. Dattani, I.C. Robinson, The molecular basis for developmental disorders of the pituitary gland in man. Clin. Genet. 57, 337–346 (2000)PubMedCrossRef M.T. Dattani, I.C. Robinson, The molecular basis for developmental disorders of the pituitary gland in man. Clin. Genet. 57, 337–346 (2000)PubMedCrossRef
6.
go back to reference S. Mody, M. Brown, J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract. Res. Clin. Endocrinol. Metab. 16, 421–431 (2002)PubMedCrossRef S. Mody, M. Brown, J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract. Res. Clin. Endocrinol. Metab. 16, 421–431 (2002)PubMedCrossRef
7.
go back to reference M.T. Dattani, Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin. Endocrinol. 63, 121–130 (2005)CrossRef M.T. Dattani, Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin. Endocrinol. 63, 121–130 (2005)CrossRef
8.
go back to reference W. Wu, J.P. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O′Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips 3rd, M.G. Rosenfeld, Mutation in PROP1 cause familial combined pituitary hormone deficiency. Nat. Genet. 18, 147–149 (1998)PubMedCrossRef W. Wu, J.P. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O′Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips 3rd, M.G. Rosenfeld, Mutation in PROP1 cause familial combined pituitary hormone deficiency. Nat. Genet. 18, 147–149 (1998)PubMedCrossRef
9.
go back to reference A.L. Rosenbloom, A.S. Almonte, M.R. Brown, D.A. Fisher, L. Baumbach, J.S. Parks, Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50–57 (1999)PubMedCrossRef A.L. Rosenbloom, A.S. Almonte, M.R. Brown, D.A. Fisher, L. Baumbach, J.S. Parks, Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50–57 (1999)PubMedCrossRef
10.
go back to reference A. Arroyo, F. Pernasetti, V.V. Vasilyev, P. Amato, S.S.C. Yen, P.L. Mellon, A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin. Endocrinol. 57, 283–291 (2002)CrossRef A. Arroyo, F. Pernasetti, V.V. Vasilyev, P. Amato, S.S.C. Yen, P.L. Mellon, A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin. Endocrinol. 57, 283–291 (2002)CrossRef
11.
go back to reference M. Doknic, S. Pekic, M. Djurovic, V. Zivkovic, V. Popovic, Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr. Endocrinol. Rev. 1, 32–33 (2004) M. Doknic, S. Pekic, M. Djurovic, V. Zivkovic, V. Popovic, Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr. Endocrinol. Rev. 1, 32–33 (2004)
12.
go back to reference M.T. Dattani, GH deficiency might be associated with normal height in PROP1 deficiency. Clin. Endocrinol. 57, 157–158 (2002)CrossRef M.T. Dattani, GH deficiency might be associated with normal height in PROP1 deficiency. Clin. Endocrinol. 57, 157–158 (2002)CrossRef
13.
go back to reference T.C. Vieira, M.R. da Silva, J. Abucham, The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 30, 365–369 (2006)PubMedCrossRef T.C. Vieira, M.R. da Silva, J. Abucham, The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 30, 365–369 (2006)PubMedCrossRef
14.
go back to reference R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, A. Barlier, Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006)PubMedCrossRef R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, A. Barlier, Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006)PubMedCrossRef
15.
go back to reference R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, T. Brue, A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J. Clin. Endocrinol. Metab. 89, 5779–5786 (2004)PubMedCrossRef R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, T. Brue, A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J. Clin. Endocrinol. Metab. 89, 5779–5786 (2004)PubMedCrossRef
16.
go back to reference J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps, M.P. Wajnrajch, Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999)PubMedCrossRef J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps, M.P. Wajnrajch, Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999)PubMedCrossRef
17.
go back to reference J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hidnmarsh, W. Wu, P.E. Mullis, “Hot spot” in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 84, 1645–1650 (1999)PubMedCrossRef J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hidnmarsh, W. Wu, P.E. Mullis, “Hot spot” in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 84, 1645–1650 (1999)PubMedCrossRef
18.
go back to reference S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J.L. Chaussain, R. Brauner, I. Pellegrini-Bouiloler, P. Jaquet, A. Enjalbert, T. Brue, PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab. 86, 4529–4535 (2001)PubMedCrossRef S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J.L. Chaussain, R. Brauner, I. Pellegrini-Bouiloler, P. Jaquet, A. Enjalbert, T. Brue, PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab. 86, 4529–4535 (2001)PubMedCrossRef
19.
go back to reference R. Reynaud, A. Barlier, S. Vallette-Kasic, A. Saveanu, M.P. Guillet, G. Simonin, A. Enjalbert, P. Valensi, T. Brue, An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J. Clin. Endocrinol. Metab. 90, 4880–4887 (2005)PubMedCrossRef R. Reynaud, A. Barlier, S. Vallette-Kasic, A. Saveanu, M.P. Guillet, G. Simonin, A. Enjalbert, P. Valensi, T. Brue, An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J. Clin. Endocrinol. Metab. 90, 4880–4887 (2005)PubMedCrossRef
20.
go back to reference B.B. Mendonca, M.G.F. Osorio, A.C. Latronico, V. Estefan, L. Su Sih Lo, I. Arnhold, Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 942–945 (1999)PubMedCrossRef B.B. Mendonca, M.G.F. Osorio, A.C. Latronico, V. Estefan, L. Su Sih Lo, I. Arnhold, Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 942–945 (1999)PubMedCrossRef
21.
go back to reference G. Agarwal, V. Bhatia, S. Cook, P.Q. Thomas, Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J. Clin. Endocrinol. Metab. 85, 4556–4561 (2000)PubMedCrossRef G. Agarwal, V. Bhatia, S. Cook, P.Q. Thomas, Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J. Clin. Endocrinol. Metab. 85, 4556–4561 (2000)PubMedCrossRef
22.
go back to reference F. Pernasetti, S.P.A. Toledo, V.V. Vasilyev, C.Y. Hayashida, J.D. Cogan, C. Ferrari, D.M. Lourenco, P.L. Mellon, Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the Prophet of Pit-1 gene. J. Clin. Endocrinol. Metab. 85, 390–397 (2000)PubMedCrossRef F. Pernasetti, S.P.A. Toledo, V.V. Vasilyev, C.Y. Hayashida, J.D. Cogan, C. Ferrari, D.M. Lourenco, P.L. Mellon, Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the Prophet of Pit-1 gene. J. Clin. Endocrinol. Metab. 85, 390–397 (2000)PubMedCrossRef
23.
go back to reference A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J.F.W. Weigel, A. Keller, W. Hirsch, W. Kiess, W.F. Blum, R.W. Pfaffle, PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab. 89, 5256–5265 (2004)PubMedCrossRef A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J.F.W. Weigel, A. Keller, W. Hirsch, W. Kiess, W.F. Blum, R.W. Pfaffle, PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab. 89, 5256–5265 (2004)PubMedCrossRef
24.
go back to reference S. Nakamura, A. Ohtsuru, N. Takamura, G. Kitange, Y. Toukunaga, A. Yasunaga, S. Shibata, S. Yamashita, Prop-1 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 84, 2581–2584 (1999)PubMedCrossRef S. Nakamura, A. Ohtsuru, N. Takamura, G. Kitange, Y. Toukunaga, A. Yasunaga, S. Shibata, S. Yamashita, Prop-1 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 84, 2581–2584 (1999)PubMedCrossRef
25.
go back to reference K. Thapar, K. Kovacs, B.W. Scheitauer, M.O. Lloyd (eds.), Diagnosis and management of pituitary tumors (Humana press, Totowa, 2001) K. Thapar, K. Kovacs, B.W. Scheitauer, M.O. Lloyd (eds.), Diagnosis and management of pituitary tumors (Humana press, Totowa, 2001)
26.
go back to reference R. Carpinteri, I. Patelli, F.F. Casanueva, A. Giustina, Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract. Res. Clin. Endocrinol. Metab. 23, 639–650 (2009)PubMedCrossRef R. Carpinteri, I. Patelli, F.F. Casanueva, A. Giustina, Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract. Res. Clin. Endocrinol. Metab. 23, 639–650 (2009)PubMedCrossRef
27.
go back to reference P. Fofanova, N. Takamura, E. Kinoshita, A. Vorontson, V. Vladimirova, I. Dedov, V. Peterkova, S. Yamashita, MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am. J. Roentgenol. 174, 555–559 (2000) P. Fofanova, N. Takamura, E. Kinoshita, A. Vorontson, V. Vladimirova, I. Dedov, V. Peterkova, S. Yamashita, MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am. J. Roentgenol. 174, 555–559 (2000)
28.
go back to reference A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, C. Dacou-Voutetakis, Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J. Clin. Endocrinol. Metab. 89, 2200–2206 (2004)PubMedCrossRef A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, C. Dacou-Voutetakis, Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J. Clin. Endocrinol. Metab. 89, 2200–2206 (2004)PubMedCrossRef
29.
go back to reference M.G. Abrao, M.V. Leite, L.R. Carvalho, A.E.C. Billerbeck, M.Y. Nishi, A.S. Barbosa, R.M. Martin, I.J.P. Arnhold, B.B. Mendonca, Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. 65, 294–300 (2006)CrossRef M.G. Abrao, M.V. Leite, L.R. Carvalho, A.E.C. Billerbeck, M.Y. Nishi, A.S. Barbosa, R.M. Martin, I.J.P. Arnhold, B.B. Mendonca, Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. 65, 294–300 (2006)CrossRef
30.
go back to reference J.S. Parks, A. Tenore, A.M. Bongiovanni, R.T. Kirkland, Familial hypopituitarism with large sella turcica. N. Engl. J. Med. 298, 698–702 (1978)PubMedCrossRef J.S. Parks, A. Tenore, A.M. Bongiovanni, R.T. Kirkland, Familial hypopituitarism with large sella turcica. N. Engl. J. Med. 298, 698–702 (1978)PubMedCrossRef
31.
go back to reference F.G. Riepe, C.J. Partsch, O. Blankenstein, H. Monig, R.W. Pfaffle, W.G. Sippell, Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J. Clin. Endocrinol. Metab. 86, 4353–4357 (2001)PubMedCrossRef F.G. Riepe, C.J. Partsch, O. Blankenstein, H. Monig, R.W. Pfaffle, W.G. Sippell, Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J. Clin. Endocrinol. Metab. 86, 4353–4357 (2001)PubMedCrossRef
32.
go back to reference C. Teinturier, S. Vallete, C. Adamsbaum, M. Bendaoud, T. Brue, P.F. Bougneres, Pseudotumor of the pituitary due to PROP-1 deletion. J. Clin. Endocrinol. Metab. 15, 95–101 (2002) C. Teinturier, S. Vallete, C. Adamsbaum, M. Bendaoud, T. Brue, P.F. Bougneres, Pseudotumor of the pituitary due to PROP-1 deletion. J. Clin. Endocrinol. Metab. 15, 95–101 (2002)
33.
go back to reference A. Zygmunt-Gorska, J. Starzyk, D. Adamek, E. Radwanska, P. Sucharski, I. Herman-Sucharska, J.J. Pietrzyk, Pituitary enlargement in patient with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. J. Pediatr. Endocrinol. Metab. 22, 653–660 (2009)PubMedCrossRef A. Zygmunt-Gorska, J. Starzyk, D. Adamek, E. Radwanska, P. Sucharski, I. Herman-Sucharska, J.J. Pietrzyk, Pituitary enlargement in patient with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. J. Pediatr. Endocrinol. Metab. 22, 653–660 (2009)PubMedCrossRef
34.
go back to reference R.D. Ward, L.T. Raetzman, H. Suh, B.M. Stone, I.O. Nasonkin, S.A. Camper, Role of PROP1 in pituitary gland growth. Endocrinol. 19, 698–710 (2005) R.D. Ward, L.T. Raetzman, H. Suh, B.M. Stone, I.O. Nasonkin, S.A. Camper, Role of PROP1 in pituitary gland growth. Endocrinol. 19, 698–710 (2005)
35.
go back to reference J.A. Loh, J.G. Verbalis, Disorders of water and salt metabolism associated with pituitary disease. Endocrinol. Metab. Clin. North Am. 37, 213–234 (2008)PubMedCrossRef J.A. Loh, J.G. Verbalis, Disorders of water and salt metabolism associated with pituitary disease. Endocrinol. Metab. Clin. North Am. 37, 213–234 (2008)PubMedCrossRef
36.
go back to reference J.G. Verbalis, S.R. Goldsmith, A. Greenberg, R.W. Schrier, R.H. Sterns, Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120(suppl 1), S1–S21 (2007)PubMedCrossRef J.G. Verbalis, S.R. Goldsmith, A. Greenberg, R.W. Schrier, R.H. Sterns, Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120(suppl 1), S1–S21 (2007)PubMedCrossRef
37.
go back to reference W.B. Schwartz, W. Bennett, S. Curelop, F.C. Bartter, A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med. 23, 529–542 (1957)PubMedCrossRef W.B. Schwartz, W. Bennett, S. Curelop, F.C. Bartter, A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med. 23, 529–542 (1957)PubMedCrossRef
38.
go back to reference I.N. Mandell, R.A. DeFronzo, G.L. Robertson, F.N.J. Forrest, Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 17, 186–195 (1950)CrossRef I.N. Mandell, R.A. DeFronzo, G.L. Robertson, F.N.J. Forrest, Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 17, 186–195 (1950)CrossRef
39.
go back to reference W. Oelkers, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med. 321, 492–496 (1989)PubMedCrossRef W. Oelkers, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med. 321, 492–496 (1989)PubMedCrossRef
40.
go back to reference R.H. Sterns, J.E. Riggs, S.S. Schochet Jr., Osmotic demyelination syndrome following correction of hyponatremia. N. Engl. J. Med. 314, 1535–1542 (1986)PubMedCrossRef R.H. Sterns, J.E. Riggs, S.S. Schochet Jr., Osmotic demyelination syndrome following correction of hyponatremia. N. Engl. J. Med. 314, 1535–1542 (1986)PubMedCrossRef
41.
go back to reference J.G. Verbalis, Hyponatremia. Endocrinologic causes and consequences of therapy. Trends Endocrinol. Metab. 3, 1–7 (1992)PubMedCrossRef J.G. Verbalis, Hyponatremia. Endocrinologic causes and consequences of therapy. Trends Endocrinol. Metab. 3, 1–7 (1992)PubMedCrossRef
42.
go back to reference A. Perianayagam, R.H. Sterns, S.M. Silver, M. Grieff, R. Mayo, J. Hix, R. Kouides, DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3, 331–336 (2008)PubMedCrossRef A. Perianayagam, R.H. Sterns, S.M. Silver, M. Grieff, R. Mayo, J. Hix, R. Kouides, DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3, 331–336 (2008)PubMedCrossRef
Metadata
Title
Case seminar: a young female with acute hyponatremia and a sellar mass
Authors
Sandra Pekic
Mirjana Doknic
Dragana Miljic
Alexandru Saveanu
Rachel Reynaud
Anne Barlier
Thierry Brue
Vera Popovic
Publication date
01-12-2011
Publisher
Springer US
Published in
Endocrine / Issue 3/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9516-8

Other articles of this Issue 3/2011

Endocrine 3/2011 Go to the issue